胆管细胞性肝癌临床归属之我见(附92例胆管细胞性肝癌与384例肝细胞性肝癌的临床分析)  

Clinical analysis of 92 cases of hepatic cholangiocarcinoma and 384 cases of hepatocellular carcinoma)

作　　者：段文斌[1] 王群伟[1] 张斌[1] 温怀玺[1] 邹亘[1] 

机构地区：[1]中南大学湘雅二医院普外科,湖南长沙410011

出　　处：《中国现代医学杂志》2009年第24期3786-3789,共4页China Journal of Modern Medicine

摘　　要：目的探讨胆管细胞性肝癌的临床归属。方法回顾性分析我院92例胆管细胞性肝癌与384例肝细胞性肝癌患者的临床资料。结果胆管细胞性肝癌与肝细胞性肝癌在术前后诊断符合率、性别、有无肝硬化、有无肝内外胆管结石病史、HBsAg阳性率、AFP阳性率、B超检查阳性率、CT检查阳性率、肿瘤位置、有无转移、手术切除率、病理分化程度等方面均存在差异,P<0.05,有统计学意义。结论胆管细胞性肝癌较肝细胞性肝癌在多个临床特征上均存在显著差异,我们认为胆管细胞性肝癌应归属于胆管癌范畴,称为胆管癌肝内型,更符合其临床特征。【Objective】To study the clinical attribution of hepatic cholangiocarcinoma.【Methods】Retrospective analyzed the clinical information of 92 cases of hepatic cholangiocarcinoma and 384 cases of hepatocellular carcinoma.【Results】 It shows that there are significant differences in diagnosis accordance rate,gender,cirrhosis,cholelithiasis history,HBsAg positive rate,AFP positive rate,B-US positive rate,CT positive rate,site of tumor,metastasis,surgery resection rate and tumor pathological differentiation degree （P 〈0.05）.【Conclusion】There are significant differences between hepatic cholangiocarcinoma and hepatocellular carcinoma in several aspects.It may be more suitable to classify hepatic cholangiocarcinoma into cholangiocarcinoma,and name it as intrahepatic cholangiocarcinoma.

关 键 词：胆管细胞性肝癌 肝细胞性肝癌 临床归属 

分 类 号：R735.7[医药卫生—肿瘤]